Ring Therapeutics
Business Services · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
620 Memorial Dr Ste 300, Cambridge, Mass...Phone Number
(202) 824-5050Website
www.ringtx.comRevenue
$23.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Ring Therapeutics
Founded in 2017, Ring is developing an in-house proprietary capability to rapidly scale manufacturing and explore the broad therapeutic potential of various Anellovectors. By implementing state-of-the-art manufacturing, Ring is planning to scale production to commercial levels and take the Anellovector platform from bench to bedside.Explore more
Ring Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ring Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Ring Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Ring Therapeutics
Check if Ring Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Ring Therapeutics launches new products
Funding: Get notified immidiatlly once Ring Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Ring Therapeutics recently announced quarterly report
Check out if Ring Therapeutics is spiking on competitors!
Ring Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Ring Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Ring Therapeutics
Compare insights from companies similar to Ring Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Ring Therapeutics
$23.2M
51-200
Private
$203.5M
2017
CW
Christopher WrightHead Chief Medical Officer, Translational Research
Company Profile Activity
Activity Insights
Ring Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Ring Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Ring Therapeutics.
Ring Therapeutics financials insights
Gather financial insights about Ring Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series B
$117M
2023
Series C
$86.5M
Ring Therapeutics Tech Stack
A closer look at the technologies used by Ring Therapeutics
See more technologies
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Lateral Move
Executive Move
Executive Moves, Lateral Move
Promotion
Executive Move
Executive Moves, Promotion
Promotion
Executive Move
Executive Moves, Promotion
Lateral Move
Executive Move
Executive Moves, Lateral Move
Ring Therapeutics News & Media
Ring Therapeutics Presents New Data on its AnelloBricks® Manufacturing Platform at the 28th Annual American Society of Gene & Cell Therapy Conference
AnelloBricks is a promising in vitro approach to producing a new class of functional viral vectors, offering dramatic advantages in manufacturing scalability and cost compared to existing vector systemsRing Therapeutics Announces New Strategic Partnerships with A*STAR and SERI to Establish Gene Therapy R&D Efforts in Singapore, a Growing Global Biotech Hub
Wide-ranging A*STAR and SERI partnership will accelerate the development of novel developmental candidates in the areas of ophthalmology and oncology, and bioprocessing technologies to support their production Wide-ranging A*STAR and SERI partnership will accelerate the development of novel developmental candidates in the areas of ophthalmology and oncology, and bioprocessing technologies to support their productionRing Therapeutics Presents Preclinical Data on Anellogy™ Platform at the 31st Annual European Society of Gene & Cell Therapy Conference
- Data further validates the AnelloVector™ platform as the first gene delivery vector system based on the human commensal anellovirusRing Therapeutics to Present Opening Keynote Lecture at the 19th International Symposium on Preparative and Industrial Chromatography and Allied Techniques (SPICA) Conference
The keynote lecture will highlight recent advancements in manufacturing technologies, including Ring Tx’s groundbreaking AnelloBricks™ platform The keynote lecture will highlight recent advancements in manufacturing technologies, including Ring Tx’s groundbreaking AnelloBricks™ platform
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Ring Therapeutics
Sign Up For FreeTo access detailed company insights
Founded in 2017, Ring is developing an in-house proprietary capability to rapidly scale manufacturing and explore the broad therapeutic potential of various Anellovectors. By implementing state-of-the-art manufacturing, Ring is planning to scale production to commercial levels and take the Anellovector platform from bench to bedside.... Read More
